Table 2.
Normothermia | Mild Heating | Heat Stress | P | |
---|---|---|---|---|
CHF patients | ||||
MAP, mmHg | 84.8 ± 3.1 | 78.0 ± 2.4* | 76.1 ± 2.6*§ | <0.001 |
SkBFarm, % | 100 | 123 ± 7† | 227 ± 39*‡§ | <0.001 |
CVCarm, % | 100 | 134 ± 8† | 251 ± 41*‡§ | <0.001 |
Tsk, °C | 33.9 ± 0.2 | 37.2 ± 0.2*†‡§ | 38.1 ± 0.1* | <0.001 |
Tcore, °C | 36.7 ± 0.1‡ | 36.9 ± 0.1*† | 37.2 ± 0.1*‡ | <0.001 |
Tbody, °C | 36.4 ± 0.1‡ | 36.9 ± 0.1*† | 37.3 ± 0.1*‡ | <0.001 |
SR, mg·cm−2·min−1 | 0.187 ± 0.034‡ | 0.318 ± 0.051*† | 0.552 ± 0.076*‡ | <0.001 |
Age-matched healthy subjects | ||||
MAP, mmHg | 88.7 ± 2.2 | 84.6 ± 1.7* | 84.2 ± 1.9* | 0.007 |
SkBFarm, % | 100 | 193 ± 32† | 545 ± 45*‡ | <0.001 |
CVCarm, % | 100 | 204 ± 35† | 580 ± 55*‡ | <0.001 |
Tsk, °C | 34.0 ± 0.1 | 37.6 ± 0.1* | 38.1 ± 0.1* | <0.001 |
Tcore, °C | 36.7 ± 0.1 | 36.9 ± 0.1† | 37.3 ± 0.1* | <0.001 |
Tbody, °C | 36.5 ± 0.1 | 36.9 ± 0.1*† | 37.4 ± 0.1* | <0.001 |
SR, mg·cm−2·min−1 | 0.118 ± 0.009 | 0.175 ± 0.015† | 0.571 ± 0.089*‡ | <0.001 |
Young healthy subjects | ||||
MAP, mmHg | 85.3 ± 1.7 | 81.1 ± 1.3* | 78.5 ± 2.1* | <0.001 |
SkBFarm, % | 100 | 227 ± 21*† | 681 ± 102* | <0.001 |
CVCarm, % | 100 | 239 ± 22*† | 753 ± 122* | <0.001 |
Tsk, °C | 34.2 ± 0.1 | 38.1 ± 0.2* | 38.3 ± 0.1* | <0.001 |
Tcore, °C | 37.0 ± 0.1 | 37.1 ± 0.1† | 37.5 ± 0.1* | <0.001 |
Tbody, °C | 36.7 ± 0.1 | 37.1 ± 0.1*† | 37.6 ± 0.1* | <0.001 |
SR, mg·cm−2·min | 0.101 ± 0.005 | 0.212 ± 0.049† | 0.948 ± 0.102* | <0.001 |
Values are means ± SE. CHF, chronic heart failure; MAP, mean arterial pressure; SkBF, skin blood flow; CVC, cutaneous vascular conductance; Tsk, skin temperature; Tcore, core temperature; SR, sweat rate.
P < 0.05 vs. normothermia.
P < 0.05 vs. heat stress within the subject group.
P < 0.05 vs. young control subjects.
P < 0.05 vs. age-matched control subjects under the respective thermal condition.